Jeremy Bender, Chief Executive Officer at Day One Biopharmaceuticals, Inc. (DAWN), sold 24,600 shares at $20.74 ($510K) on 2022-11-21, disclosed to the SEC on 2022-11-22.
Open-market sale of $510k DAWN by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.74 | 12,100 | $251K | 49.2% |
| 2 | $20.74 | 12,100 | $251K | 49.2% |
| 3 | $21.38 | 400 | $9K | 1.7% |
| Total | $20.75 avg | 24,600 | $510K | 100% |
| Filing → |
| DAWN | SELL | 2025-08-19 | $217K | — | Filing → |
| DAWN | SELL | 2025-05-19 | $175K | — | Filing → |
| DAWN | SELL | 2025-02-21 | $288K | — | Filing → |